Bioventus Inc. (BVS) Financials

$10.01

north_east
$0.06 (0.6%)
Day's range
$9.86
Day's range
$10.26
$600M$600M$400M$400M$200M$200M$0$0-$200M-$200M-$400M-$400MEarning2017201720182018201920192020202020212021202220222023202350%50%30%30%10%10%-10%-10%-30%-30%-50%-50%Profit Margin
Profit Margin
Revenue
Earnings

BVS Income statement / Annual

Last year (2023), Bioventus Inc.'s total revenue was $512.35 M, an increase of 0.04% from the previous year. In 2023, Bioventus Inc.'s net income was -$156.23 M. See Bioventus Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $512.35 M $512.12 M $430.90 M $321.16 M $340.14 M $319.18 M $292.06 M $274.50 M $253.65 M $242.89 M
Cost of Revenue $184.15 M $181.04 M $128.19 M $87.64 M $90.94 M $84.17 M $92.10 M $91.39 M $74.34 M $74.61 M
Gross Profit $328.19 M $331.08 M $302.71 M $233.52 M $249.21 M $235.01 M $199.96 M $183.11 M $179.31 M $168.28 M
Gross Profit Ratio 0.64 0.65 0.7 0.73 0.73 0.74 0.68 0.67 0.71 0.69
Research and Development Expenses $13.45 M $25.94 M $19.04 M $11.20 M $11.06 M $8.10 M $8.10 M $7.90 M $14.75 M $9.47 M
General & Administrative Expenses $300.03 M $327.40 M $250.38 M $190.31 M $196.12 M $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $3.85 M $5.20 M $3.87 M $2.77 M $2.35 M $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $303.88 M $332.61 M $254.25 M $193.08 M $198.48 M $191.67 M $164.84 M $160.32 M $148.44 M $147.06 M
Other Expenses $92.59 M $21.15 M $8.36 M $7.44 M $7.91 M -$226,000.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $409.92 M $379.70 M $281.66 M $211.72 M $217.44 M $207.64 M $172.94 M $168.22 M $173.76 M $165.49 M
Cost And Expenses $594.07 M $560.74 M $409.85 M $299.36 M $308.37 M $291.81 M $265.04 M $259.61 M $248.10 M $240.10 M
Interest Income $0.00 $25.80 M $1.11 M $9.75 M $21.58 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $40.68 M $25.80 M $1.11 M $9.75 M $21.58 M $19.17 M $18.90 M $15.94 M $14.23 M $11.97 M
Depreciation & Amortization $57.37 M $61.40 M $38.68 M $28.64 M $30.32 M $29.24 M $32.29 M $33.76 M $33.08 M $28.82 M
EBITDA -$23.07 M -$109.21 M $51.81 M $50.44 M $61.58 M $54.52 M $59.32 M $48.65 M $15.18 M $34.42 M
EBITDA Ratio -0.05 0.06 0.12 0.17 0.18 0.18 0.2 0.18 0.15 0.13
Operating Income Ratio -0.16 -0.07 0.04 0.07 0.09 0.08 0.09 0.05 -0.07 0
Total Other Income/Expenses Net -$39.39 M -$21.79 M -$2.57 M -$5.32 M -$21.50 M -$19.40 M -$18.37 M -$20.54 M -$15.38 M -$11.37 M
Income Before Tax -$121.11 M -$263.90 M $7.62 M $15.91 M $9.69 M $6.11 M $8.66 M -$5.65 M -$31.97 M -$11.35 M
Income Before Tax Ratio -0.24 -0.52 0.02 0.05 0.03 0.02 0.03 -0.02 -0.13 -0.05
Income Tax Expense $85,000.00 -$50.51 M -$1.97 M $1.19 M $1.58 M $1.66 M -$785,000.00 $1.09 M $2.14 M $1.55 M
Net Income -$156.23 M -$213.39 M $9.59 M $16.41 M $6.85 M -$12.21 M -$1.64 M -$17.95 M -$34.11 M -$12.90 M
Net Income Ratio -0.3 -0.42 0.02 0.05 0.02 -0.04 -0.01 -0.07 -0.13 -0.05
EPS -2.49 -3.48 0.16 0.0771 -0.0116 -0.22 -0.0288 -0.32 -0.61 -0.23
EPS Diluted -2.49 -3.48 0.16 0.0771 -0.0116 -0.22 -0.0288 -0.32 -0.61 -0.23
Weighted Average Shares Out $62.65 M $61.39 M $59.55 M $56.83 M $56.83 M $55.63 M $56.83 M $56.83 M $55.63 M $55.63 M
Weighted Average Shares Out Diluted $62.65 M $61.39 M $59.55 M $56.83 M $56.83 M $55.63 M $56.83 M $56.83 M $55.63 M $55.63 M
Link